Task: Answer the multiple choice question.
Query: Which drug exhibits a 0.933\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: COCCn1nnnc1C(c1ccccc1OC)N1CCN(c2ccccc2)CC1.Cl
b: S=C(NC12CC3CC(CC(C3)C1)C2)N1CCCC1
c: Cc1csc2ncnc(N3CCN(C(=O)Nc4ccc(OC(F)(F)F)cc4)CC3)c12
Answer: c. Cc1csc2ncnc(N3CCN(C(=O)Nc4ccc(OC(F)(F)F)cc4)CC3)c12
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1csc2ncnc(N3CCN(C(=O)Nc4ccc(OC(F)(F)F)cc4)CC3)c12
Cc1csc2ncnc(N3CCN(C(=O)Nc4ccc(OC(F)(F)F)cc4)CC3)c12
4-(5-methylthieno[2,3-d]pyrimidin-4-yl)-N-[4-(trifluoromethoxy)phenyl]piperazine-1-carboxamide